Compound information
- Natural Products
- ZC2181400
- Molecular Formula
- C16H13F2N3O2S
- Molecular Weight
- 349.069654096 g/mol
- Structure
-
- IUPAC Name
- 1-(4,6-difluoro-1,3-benzothiazol-2-yl)-3-[(4-methoxyphenyl)methyl]urea
- InChI
- InChI=1S/C16H13F2N3O2S/c1-23-11-4-2-9(3-5-11)8-19-15(22)21-16-20-14-12(18)6-10(17)7-13(14)24-16/h2-7H,8H2,1H3,(H2,19,20,21,22)
- InChI Key
- NVJWSHNXWUJJJF-UHFFFAOYSA-N
- SMILES
- COc1ccc(CNC(=O)Nc2nc3c(F)cc(F)cc3s2)cc1
- Source
- ZINC000038488582
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 63.25 Å2 | LogP | 3.736 |
LogS | -4.875 | LogD | 4.31 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.996 | Pgp substrate | 0.789 |
HIA | 0.961 | F20 % | 0.993 |
F30 % | 0.795 | Caco-2 | -4.695 |
MDCK | -4.705 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.14 | PPB | 100.068 |
VD | 0.956 | Fu | 1.965 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.991 | CYP1A2 substrate | 0.886 |
CYP2A6 substrate | 0.805 | CYP2B6 substrate | 0.743 |
CYP2C19 inhibitor | 0.901 | CYP2C19 substrate | 0.95 |
CYP2C8 substrate | 0.889 | CYP2C9 inhibitor | 0.918 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.257 |
CYP2D6 substrate | 0.788 | CYP2E1 substrate | 0.773 |
CYP3A4 inhibitor | 0.741 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.21 | CL | 8.567 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.016 | Hepatotoxicity | 0.972 |
Mutagenicity | 0.074 | Rat Oral Acute Toxicity | 0.023 |
FDAMDD | 0.45 | Skin Sensitization | 0.522 |
Carcinogenicity | 0.43 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.032 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.286 | IGC50 | 3.722 |
LC50FM | 4.544 | LC50DM | 6.219 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.66 | NR-AR-LBD | 0.417 |
NR-AhR | 0.985 | NR-Aromatase | 0.04 |
NR-ER | 0.651 | NR-ER-LBD | 0.322 |
NR-PPAR-gamma | 0.748 | SR-ARE | 0.812 |
SR-ATAD5 | 0.774 | SR-HSE | 0.051 |
SR-MMP | 0.909 | SR-p53 | 0.666 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.